FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice.
Fibroblast growth factor 23 (FGF23) is a circulating hormone important in phosphate homeostasis. Abnormal serum levels of FGF23 result in systemic pathologies in humans and mice, including renal phosphate wasting diseases and hyperphosphatemia. We sought to uncover the role FGF23 plays in the audito...
Guardado en:
Autores principales: | Andrew C Lysaght, Quan Yuan, Yi Fan, Neil Kalwani, Paul Caruso, MaryBeth Cunnane, Beate Lanske, Konstantina M Stanković |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bf0e45ea0da74dad906e54f2eefd8c43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A novel cochlear measurement that predicts inner-ear malformation
por: Tawfiq Khurayzi, et al.
Publicado: (2021) -
A gene network regulated by FGF signalling during ear development
por: Maryam Anwar, et al.
Publicado: (2017) -
Sex and species specific hearing mechanisms in mosquito flagellar ears
por: Matthew P. Su, et al.
Publicado: (2018) -
Recurrent glomangioma (“true” glomus tumor) of the middle ear and mastoid
por: Adam C. Kaufman, et al.
Publicado: (2019) -
“To Those Who Have Ears to Hear:” Clement of Alexandria on the Parables of Jesus
por: Vennerstrom Carl
Publicado: (2021)